These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 24377556)

  • 1. Clinical and pathologic features of patients with rare ovarian tumors: multi-center review of 167 patients by the anatolian society of medical oncology.
    Bilici A; Inanc M; Ulas A; Akman T; Seker M; Babacan NA; Inal A; Bal O; Koral L; Sevinc A; Tufan G; Elkiran ET; Ustaalioglu BB; Yavuzsen T; Alkis N; Ozkan M; Gumus M
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6493-9. PubMed ID: 24377556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and pathologic features of patients with non-epithelial ovarian cancer: retrospective analysis of a single institution 15-year experience.
    Kempf E; Desamericq G; Vieites B; Diaz-Padilla I; Calvo E; Estevez P; Garcia-Arreza A; Martinez-Maestre MA; Duran I
    Clin Transl Oncol; 2017 Feb; 19(2):173-179. PubMed ID: 27193130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of lymph node staging method and prognostic factors in malignant ovarian sex cord-stromal tumors: A world wide database analysis.
    Wang J; Li J; Chen R; Lu X
    Eur J Surg Oncol; 2018 Jul; 44(7):1054-1061. PubMed ID: 29705285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--an analysis of 376 women.
    Zhang M; Cheung MK; Shin JY; Kapp DS; Husain A; Teng NN; Berek JS; Osann K; Chan JK
    Gynecol Oncol; 2007 Feb; 104(2):396-400. PubMed ID: 17030354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Analysis of Prognostic Factors in Patients with Ovarian Malignant Germ Cell Tumors Who Are Treated with Fertility-Preserving Surgery.
    Yang ZJ; Liu ZC; Wei RJ; Li L
    Gynecol Obstet Invest; 2016; 81(1):1-9. PubMed ID: 25967958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laparoscopic management of early-stage malignant nonepithelial ovarian tumors: surgical and survival outcomes.
    Shim SH; Kim DY; Lee SW; Park JY; Kim JH; Kim YM; Kim YT; Nam JH
    Int J Gynecol Cancer; 2013 Feb; 23(2):249-55. PubMed ID: 23318909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--a multivariate analysis.
    Chan JK; Zhang M; Kaleb V; Loizzi V; Benjamin J; Vasilev S; Osann K; Disaia PJ
    Gynecol Oncol; 2005 Jan; 96(1):204-9. PubMed ID: 15589602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of rare ovarian cancers: the experience of the French website "Observatory for rare malignant tumours of the ovaries" by the GINECO group: interim analysis of the first 100 patients.
    Ray-Coquard I; Weber B; Lotz JP; Tournigand C; Provencal J; Mayeur D; Treilleux I; Paraiso D; Duvillard P; Pujade-Lauraine E;
    Gynecol Oncol; 2010 Oct; 119(1):53-9. PubMed ID: 20580063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors of germ cell and sex cord-stromal ovarian tumors in pediatric age: 5 years experience.
    Elashry R; Hemida R; Goda H; Abdel-Hady el-S
    J Exp Ther Oncol; 2013; 10(3):181-7. PubMed ID: 24416992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of lymphadenectomy on prognosis and survival of clinically apparent early-stage malignant ovarian germ cell tumors.
    Qin B; Xu W; Li Y
    Jpn J Clin Oncol; 2020 Mar; 50(3):282-287. PubMed ID: 31867612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of lymphadenectomyin malignant ovarian sex cord stromal tumor: A retrospective cohort study and meta-analysis.
    Cheng H; Peng J; Yang Z; Zhang G
    Gynecol Oncol; 2018 Jan; 148(1):91-96. PubMed ID: 29107349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of surgery and chemotherapy in ovarian sex cord-stromal tumors from the multicentric Salomé study including 469 patients. A TMRG and GINECO group study.
    Hanvic B; Lecuru F; Vanacker H; Pautier P; Narducci F; Cherifi F; Floquet A; Angeles MA; Berton D; Pomel C; Kalbacher E; Provansal M; Fernandez Y; Rouge TM; Roméo C; Laas E; Morice P; Hudry D; Meriaux E; Guyon F; Illac-Vauquelin C; Selle F; Meeus P; Genestie C; Salleron J; Ray-Coquard I
    Gynecol Oncol; 2023 Jul; 174():190-199. PubMed ID: 37210929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome and risk factors for recurrence in malignant ovarian germ cell tumors: a MITO-9 retrospective study.
    Mangili G; Sigismondi C; Gadducci A; Cormio G; Scollo P; Tateo S; Ferrandina G; Greggi S; Candiani M; Lorusso D
    Int J Gynecol Cancer; 2011 Nov; 21(8):1414-21. PubMed ID: 21795985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
    Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
    [No Abstract]   [Full Text] [Related]  

  • 15. Management and prognosis of patients with ovarian sex cord tumor with annular tubules: a retrospective study.
    Qian Q; You Y; Yang J; Cao D; Zhu Z; Wu M; Chen J; Lang J; Shen K
    BMC Cancer; 2015 Apr; 15():270. PubMed ID: 25886261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
    Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
    Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant ovarian germ cell tumors: clinico-pathological presentation and survival outcomes.
    Tangjitgamol S; Hanprasertpong J; Manusirivithaya S; Wootipoom V; Thavaramara T; Buhachat R
    Acta Obstet Gynecol Scand; 2010; 89(2):182-9. PubMed ID: 19961281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of prognostic factors of malignant ovarian tumor after fertility-preserving treatment].
    Zeng DY; Shen K; Huang HF; Wu M; Pan LY; Yang JX; Lang JH
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(36):2562-5. PubMed ID: 16321304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Multicenter randomized controlled clinical study for the operative treatment of malignant ovarian germ cell tumors].
    Liu Q; Ding XL; Yang JX; Cao DY; Shen K; Lang JH; Zhang GN; Xin XY; Xie X; Zhang SL; Wu YM; Zhu GH; Wang J; Chen YL; Kong BH; Zheng JH
    Zhonghua Fu Chan Ke Za Zhi; 2013 Mar; 48(3):188-92. PubMed ID: 23849941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic analysis of early-stage sporadic ovarian carcinoma.
    Leitao MM; Boyd J; Hummer A; Olvera N; Arroyo CD; Venkatraman E; Baergen RN; Dizon DS; Barakat RR; Soslow RA
    Am J Surg Pathol; 2004 Feb; 28(2):147-59. PubMed ID: 15043303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.